A study presented at the 2016 Palliative Care in Oncology Symposium has found that a majority users of the provisions under Oregon's Death With Dignity Act had cancer and most of them chose to die at home.
To date, 4 states in the United States have enacted the Death With Dignity Act: Oregon, Washington, Vermont, and California. Oregon was the first state in 1997 to do so, following a voter initiative; California is the latest (2016). A new study, presented at the 2016 Palliative Care in Oncology Symposium hosted by the American Society of Clinical Oncology, provides an update on patient demographics and participation trends in the state of Oregon.
In this pioneer state, the Death With Dignity Act was initiated on October 27, 1997, to provide terminally-ill individuals to end their lives through voluntary self-administration of physician-prescribed lethal medications. The Oregon Health Authority is mandated to gather information on participating providers and patients—so for their study, the authors reviewed, collated, and interpreted data collected from prescribing/consulting physicians, pharmacists, and psychiatrists between 1998 and early 2016.
The authors report that 1545 prescriptions were written during the entire period that the Oregon Death With Dignity Act has been active. Less than a 1000 of those prescriptions were used—991 patient deaths from legally prescribed lethal drugs were reported. Growing awareness about the Act could be responsible for the rise in prescriptions, which increased at an average rate of 12% per year till 2013 and more than doubled to 28% in 2014 and to 40% in 2015. Of the 991 patients who died,
Only about 5% of the patients received psychiatric evaluation. According to provisions within the law, a referral is at the discretion of the attending or consulting physician.
While there was no gender bias in those who died (male/female: 51.4%/48.6%), patients who took the lethal dose tended to be older (median age 71 years) and white (97%), the authors found. Further, a majority of them chose hospice care (90.5%) and most died at home (94%).
The most common reasons reported for choosing death with dignity were not being able to enjoy daily activities (90%) and the loss of autonomy (92%). Only a quarter of the patients listed inadequate pain palliation as the reason for their choice to end life.
Reference
Blanke CD, LeBlanc ML, Hershman DL, Ellis LM, Meyskens FL. Usage of Oregon’s Death With Dignity Act (DWDA). J Clin Oncol. 2016;34(suppl 26S; abstract 44).
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More